483
Douglas Glenn Young, M.D.Douglas Glenn Young, M.D. – FDA 483, Nov 20, 2023
Record Details
An FDA inspection of Clinical Investigator Douglas Glenn Young in Sacramento, CA, revealed significant deviations from the investigational plan. The inspection found that staff were not properly trained prior to performing clinical trial activities, leading to incorrect dosing of investigational drugs for multiple subjects. These findings indicate a failure to ensure proper conduct and oversight of the clinical study.
View Company Profile
ID · 0ce42acc-542f-4e2a-9181-d7a35da2305b
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.